TNF and melanoma: These findings are in accordance with previously published data showing improved treatment outcomes in rat osteosarcoma and murine melanoma tumor models that were treated with low-dose TNF-α plus liposomal doxorubicin in comparison to TNF-α plus free doxorubicin [5, 91].